Life Sciences Updates from Cooley Godward Kronish LLPhttp://www.cooley.com<p>Partner <a href="http://www.cooley.com/wfishburn" target=_self>Wain Fishburn</a> commented on the changing relationship between biotech companies and big pharmaceutical companies. His remarks were made during a panel discussion sponsored by BIOCOM, a life sciences industry group in San Diego, and...http://www.cooley.com/showinthenews.aspx?Show=63410Thu, 19 Nov 2009 00:00:00 GMT<p><em>The Cooley team representing Alder Biopharmaceuticals included partners <a href="bkosacz">Barbara Kosacz</a>, <a href="mpostner">Marya Postner</a>, <a href="serickson">Sonya Erickson</a>, and special counsel <a href="gempey">Gordon Empey</a> and <a href="dleith">Deb Leith</a>.&nbsp;</em></p> ...http://www.cooley.com/showpressrelease.aspx?Show=63333Tue, 10 Nov 2009 00:00:00 GMT<p><em>The Cooley team representing Medivation included partners Robert Jones and Barbara Kosacz and associate Shane Albright. </em></p> <p>TOKYO and SAN FRANCISCO, Oct 27, 2009 -- Astellas Pharma Inc. ("Astellas") and Medivation, Inc. (Nasdaq: MDVN) announced today that they have entered into a gl...http://www.cooley.com/showpressrelease.aspx?Show=63279Tue, 27 Oct 2009 00:00:00 GMT<p><em>The Cooley team representing Proteolix was led by partners&nbsp;<a href="http://www.cooley.com/hooperss" target=_self>Suzanne Sawochka Hooper&nbsp;</a>and <a href="http://www.cooley.com/bkosacz" target=_self>Barbara Kosacz</a>, and included associates <a href="http://www.cooley.com/mpark" tar...http://www.cooley.com/showpressrelease.aspx?Show=63241Mon, 12 Oct 2009 00:00:00 GMT<p><strong>San Diego – Sept. 17, 2009 --</strong> Cooley Godward Kronish announced today that <a href="http://www.cooley.com/mutoft" target=_self>Fred Muto</a>, the head of the firm's San Diego office, was named the 2010 Corporate Lawyer of the Year in San Diego by Best Lawyers. <br>&nbsp;<br>A reco...http://www.cooley.com/showpressrelease.aspx?Show=63151Thu, 17 Sep 2009 00:00:00 GMT<p><em>In Vivo </em>Blog recently interviewed Barbara Kosacz, national head of Cooley's Life Sciences practice. The podcast provides interesting commentary and dealmaking insight for the biotech industry. <u><a href="http://invivoblog.blogspot.com/2009/07/in-vivo-blog-podcast-inside-view-of.html" ta...http://www.cooley.com/showinthenews.aspx?Show=63053Thu, 02 Jul 2009 00:00:00 GMT<strong>Palo Alto, Calif.</strong> – <strong>June&nbsp;22, 2009&nbsp;</strong> – Cooley Godward Kronish LLP is pleased to announce that the seventh annual <i>Chambers USA:</i> <i>America's Leading Lawyers for Business</i> honors 43 of the Firm's attorneys as leaders in their respective fields, with ...http://www.cooley.com/showpressrelease.aspx?Show=62673Mon, 22 Jun 2009 00:00:00 GMT<p><span class="body">Cooley advised Gilead Sciences in an agreement to aquire CV Therapeutics, a maker of cardiovascular drugs like Ranexa and Lexiscan. The deal will prevent a hostile bid by Astellas Pharma and complement the company's cardiovascular portfolio.</span></p><p><strong><span class="bo...http://www.cooley.com/showinthenews.aspx?Show=58960Thu, 12 Mar 2009 00:00:00 GMT<p><em>Cooley Godward Kronish represented Verenium Corporation in this transaction. Team members included Kay Chandler, Amy Hallman Rice, Daniel P. Meehan, Robert O. Hadfield and Wain Fishburn.</em></p><p>CAMBRIDGE, Mass., Feb 18, 2009 /PRNewswire-FirstCall via COMTEX/ -- BP and Verenium Corporation...http://www.cooley.com/showpressrelease.aspx?Show=58933Thu, 19 Feb 2009 00:00:00 GMT<p>New Year's was nice, but Christmas and Thanksgiving are a blur for Cooley Godward Kronish attorneys who worked around the clock to get a deal solidified between two pharmaceutical companies before an accounting rule affecting mergers changed Jan. 1.</p> <p>Aliso Viejo's Valeant Pharmaceuticals...http://www.cooley.com/showinthenews.aspx?Show=58929Thu, 05 Feb 2009 00:00:00 GMT